CME Group (CME) February option implied volatility into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Citi on CME Group (CME): 'We remain constructive on the stock'
February 14, 2024 7:49 AM ESTCiti analyst Chris Allen reiterated a Buy rating and $240.00 price target on CME Group (NASDAQ: CME)
The analyst comments "CME reported 4Q23 adj. EPS of $2.37 (vs our est/consensus of $2.30/2.28). Revenue came in above our expectations at $1.44B (vs est. of $1.42B), with... More



